Acute opioid receptor desensitization and tolerance: Is there a link?

Clinical and Experimental Pharmacology and Physiology

Volumn 28, Issue 3, 2001, Pages 147-154

  Borgland, Stephanie L ^a,b  

^a University of Sydney   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Addiction; Desensitization; Morphine; Opioid receptors; Tolerance

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE DERIVATIVE; MU OPIATE RECEPTOR; OPIATE RECEPTOR; PROTEIN FOS;

CELL MEMBRANE; DESENSITIZATION; DISEASE ASSOCIATION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERANCE; HUMAN; PAIN; PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DRUG TOLERANCE; HUMANS; NARCOTICS; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION;

EID: 0035128485     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2001.03418.x     Document Type: Review

References (89)

1. Cellular and molecular mechanism of drug dependence
2. Drug addiction: A model for the molecular basis of neural plasticity
3. Molecular and cellular basis of addiction
4. Opiate tolerance and dependence: Receptors, G-proteins, and antiopiates
5. Regulation of opioid receptor activities
6. Classification of opioid receptors
7. Structure and function of G protein-coupled receptors
8. Opioid receptor signalling mechanisms
9. Opioid actions on membrane ion channels
10. G protein βγ subunits
11. A mitogen-activated protein kinase pathway is required for μ-opioid receptor desensitization
12. Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway
13. Linkage of G protein-coupled receptors to the MAPK signaling pathway through P13-kinase gamma
14. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes
15. Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: Biochemical and immunofluorescence confocal microscopic evidence
16. Making new connections: Role of ERK/MAP kinase signalling in neuronal plasticity
17. The role of receptor kinases and arrestins in G protein-coupled receptor regulation
18. Chronic morphine administration increases beta-adrenergic receptor kinase (beta ARK) levels in the rat locus coeruleus
19. Desensitization of the delta-opioid receptor correlates with its phosphorylation in SK-N-BE cells: Involvement of a G protein-coupled receptor kinase
20. 2+ channel inhibition and its desensitization in NG108-15 cells
21. Transient homologous μ-opioid receptor desensitization in rat locus coeruleus neurons
22. + channel
23. The human opioid receptor: Modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C
24. II-phospholipase C activation in Xenopus oocytes
25. 2-adrenergic receptor resensitization
26. 2+/calmodulin-dependent protein kinase
27. Site mutation in the rat μ-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization
28. Agonist-induced. G-protein dependent and independent down-regulation of the μ-opioid receptor
29. Characterization of acute homologous desensitizaton of μ-opioid receptor-induced currents in locus coeruleus neurones
30. Molecular cloning of rat G-protein-coupled receptor kinase 6 (GRK6) from brain tissue, and its mRNA expression in different brain regions and peripheral tissues
31. The effect of inhibitors of receptor internalization on the desensitization and resensitization of three Gs-coupled receptor responses
32. 35S]-thio)triphosphate binding
33. Molecular mechanisms of G protein-coupled receptor desensitization and resensitization
34. Arrestin function in inactivation of G protein-coupled receptor rhodopsin in vivo
35. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization
36. Differential μ opiate receptor phosphorylation and desensitization induced by agonist and phorbol esters
37. Morphine activates opioid receptors without causing their rapid internalization
38. μ-Opioid receptor internalization: Opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain
39. Agonist-selective endocytosis of mu opioid receptor by neurons in vivo
40. Functional dissociation of μ opioid signaling and endocytosis: Implications for the biology of opiate tolerance and dependence
41. Loss of receptor activity in neuroblastoma × glioma NG108-15 hybrid cells after chronic opiate treatment: A multiple step process
42. δ and κ opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist
43. Sequestration of the δ-opioid receptor
44. Agonist-induced signaling and trafficking of the mu-opioid receptor: Role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain
45. U50 488H-induced internalization of the human κ opioid receptor involves a β-arrestin- and dynamin-dependent mechanism
46. Dimerization of the δ opioid receptor: Implication for a role in receptor internalization
47. Carboxyl-terminal splicing of the rat μ opioid receptor modulates agonist-mediated internalization and receptor resensitization
48. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells
49. Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness
50. Opioid modulation of extracellular signal-regulated protein kinase activity is Ras-dependent and involves Gβγ subunits
51. The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express μ-opioid receptors
52. The MAPK cascade is required for mammalian associative learning
53. Under siege: The brain on opiates
54. Molecular mechanisms of drug reinforcement and addiction
55. Where is the locus in opioid withdrawal?
56. Opiate withdrawal and the rat locus coerelus: Behavioural, electro-physiological, and biochemical correlates
57. Role of different brain structures in the expression of the physical morphine withdrawal syndrome
58. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
59. Opioid tolerance and dependence in the magnocellular oxytocin system: A physiological mechanism?
60. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gβγ
61. Opiate-induced adenylyl cyclase superactivation is isozyme specific
62. Morphine receptors as regulators of adenylate cyclase activity
63. 1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma × glioma (NG108-15) hybrid cells chronically exposed to an opioid
64. Increased probability of GABA release during withdrawal from morphine
65. Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal
66. B- mediated synaptic potentials in the ventral tegmental area during morphine withdrawal
67. Enhanced opioid efficacy in opioid dependence is due to an additional signal transduction pathway
68. How opioids inhibit GABA-mediated neurotransmission
69. Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA
70. CREB in the locus coeruleus: Biochemical, physiological, and behavioral evidence for a role in opiate dependence
71. CREB (cAMP response element-binding protein) in the locus coeruleus: Biochemical, physiological, and behavioral evidence for a role in opiate dependence
72. Regulation of cocaine reward by CREB
73. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration
74. Chronic Fos-related antigens: Stable variants of deltaFosB induced in brain by chronic treatments
75. Learning mechanisms: The case for CaM-KII
76. DeltaFosB: A molecular mediator of long-term neural and behavioral plasticity
77. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells
78. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells
79. Selective and interactive down regulation of μ- and δ-opioid receptors in human neuroblastoma SK-N-SH cells
80. Decrease in μ-opioid binding capacity in rat brain after chronic PLO17 treatment
81. Down-regulation of brain and spinal cord μ-opiate receptors in morphine tolerant-dependent rats
82. Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist
83. Morphine tolerance increases μ-noncompetitive δ binding sites
84. 3H][D-Ala.MePhe,Glyol]enkephalin: Further evidence for two μ-binding sites
85. A rapid and simple method for the quantitative determination of tolerance development to opiates in the guinea-pig ileum in vitro
86. The effect of intrinsic efficacy on opioid tolerance
87. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home
88. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling
89. Physical dependence of opiate-like peptides